Nephron Pharmaceuticals Corporation
Contract Manufacturing
503B Outsourcing
Respiratory Medication Production
4500 12th Street Extension West Columbia, SC 29172
会社名
Group 親会社 子会社 得意先 仕入先 業務提携 銀行等 株主等
Roper St. Francis
グループ会社 親会社 子会社 得意先 仕入先 業務提携 銀行・融資・与信 出資・持分・株主
得意先

70 件
日付概要
1997年 Albuterol 0.083% Inhalation Solution ANDA approved
1998年 Applied for Albuterol 0.5% Inhalation Solution ANDA
1998年 Nephron expanded operations to 56,000 sq. ft.
1999年 Helping patients breathe easy
2000年 Alleviating respiratory discomfort
2000年 S2 Racepinephrine Inhalation Solution launched
2001年 Swift growth
2001年 Albuterol 0.5% Inhalation Solution ANDA approved
2001年 Ipratropium Bromide 0.02% Inhalation Solution ANDA approved
2001年 Expansion to 76,000 sq.ft.
2001年 Addition of single vial, bar coded packaging
2002年 Getting the word out
2002年 Lou Kennedy comes on board and begins to build marketing sales force
2003年 Amplifying production
2003年 Addition of 4 new Blow-Fill-Seal machines increased capacity to 58 million vials per month
2004年 A breath of fresh air
2004年 Albuterol 0.042% Inhalation Solution ANDA approved
2005年 Automation promotes accuracy
2005年 Launched the Electronic Fill Weights – EBR Manager
2006年 Keeping up with demand
2006年 Nephron acquires its first pieces of Bosch high-speed packaging machinery
2007年 Improving efficiency and speed
2007年 Ipratropium Bromide 0.5mg/ Albuterol Sulfate 3mg Inhalation Solution (DuoDose) ANDA approved
2007年 Addition of a High Speed Single Vial Packaging Line – 35,000 vials per hour
2007年 Advanced Processes and Quality Controls
2008年 A year of continued growth
2008年 Manufacturing Facility Expansion: Construction of an additional formulation weigh suite and filling suite
2008年 Addition of Rommelag BFS Machines to increase capacity by 18 million vials per month
2009年 Fighting for a level playing field
2009年 Bill Kennedy hearing before the US House of Representatives on H.R. 1706: Protecting Consumer Access to Generic Drugs Act of 2009
2010年 Expanding our reach
2010年 Albuterol 0.021% Inhalation Solution ANDA approved
2010年 Nephron expands distribution facilities with the purchase of a warehouse in Phoenix, AZ
2010年 Murray, KY warehouse expanded to 150,000 sq. ft.
2011年 A new economic driver for the Midlands
2011年 Nephron announced that the company would locate its new operations in Lexington County.
2011年 $313 million investment is expected to generate 707 new jobs.
2012年 Relief, now OTC
2012年 Sodium Chloride (hypertonic saline) 3% and 7% launched
2012年 Nephron SC breaks ground
2012年 Launch of our first OTC Medication Asthmanefrin
2013年 Efficiency through automation
2013年 The fabrication of the new palletizing systems for the lines at Nephron’s South Carolina facility completed
2015年 After 16 long months, Nephron finally receives full FDA approval
2016年 Budesonide 0.25mg and 0.5mg received ANDA approval
2016年 National launch of the Pocket Neb
2017年 Nephron 503B Outsourcing Facility officially launched
2017年 Became licensed in all 50 states
2018年 Released new opioid free alternatives
2018年 Established free overnight delivery via UPS
2018年 Reached a total of 900+ employees
2018年 Launched a $12.5 million expansion
2019年 Launched an educator program that employs over 860 local teachers
2019年 Reached a total of 2000+ FTE and PTE employees
2019年 Added 75,000 square feet of clean room manufacturing space
2019年 Installed 4 new sterile BFS lines
2020年 Nephron steps up to respond to COVID-19, seeking FDA approval to ramp up production
2020年 Opened a CLIA-certified Diagnostics Lab and began COVID-19 testing for employees, families and businesses in the Midlands and across South Carolina
2020年 Launched production of FDA approved hand sanitizer
2020年 Broke ground on a historic $215M expansion, including a vaccine production facility
2020年 Announced plans for a Kennedy Innovation Complex
2020年 Received FDA approval of an Abbreviated New Drug Application (ANDA) for two new products – 0.9% Sodium Chloride IV Bags, and Ketorolac Tromethamine Injection Vials
2021年 With the launch of Nephron Nitrile, a glove manufacturing venture, Nephron begins a $100 million construction project, adding a new 400,000 square-foot facility to its campus of existing facilities and hiring 250 new workers in the process
2021年 Continued combating the scourge of the COVID-19 pandemic by producing testing chemicals known as reagents, as well as the test kits themselves
2021年 Partnered with Dominion Energy to open the Nephron Clinical Lab–a way to support Midlands-area residents with fast, reliable COVID-19 vaccination and testing services
2021年 Developed a new wing of existing Nephron facilities where manufacturers can focus on the creation of life-saving antibiotics and chemotherapy drugs
2021年 Announced a new syringe and equipment manufacturing venture, Inject EZ
2021年 Partnered with the ISPE Foundation to launch a new internship program, which aims to diversify Nephron’s ever-growing employee base
2022年 Nephron 503B launched a new, innovative syringe presentation – the Cyclic Olefin Copolymer (COC) syringe
2022年 Owner and CEO Lou Kennedy received a National Manufacturing Icon Award from the National Association of Manufacturers (NAM)
+ 開くと読み込みます
2026-08-26 03:59 (Model: ggml-org/gpt-oss-20b )
↑